Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-15 Sale | 2019-05-16 9:37 pm | Retrophin Inc. | RTRX | McFarlane Neil F. Chief Operating Officer | 1,968 | $18.25 | $35,906 | 26,988 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 8:10 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO | 700,000 | $0 | 700,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 4:33 pm | N/A 2033-10-09 | ZEVRA THERAPEUTICS INC. | ZVRA | McFarlane Neil F. President and CEO | 800,000 | $0 | 800,000 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-19 4:40 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director | 9,792 | $0 | 41,672 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 4:44 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director | 14,035 | $0 | 31,880 (Direct) | View |
| 2022-04-06 Option Award | 2022-04-08 5:12 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director | 17,845 | $0 | 17,845 (Direct) | View |
Ownership | 2022-04-08 5:11 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director | 0 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 75,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:10 pm | N/A 2029-09-15 | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 450,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 600,000 | $0 | 0 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-03 5:01 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 300,000 | $0 | 525,000 (Direct) | View |
| 2020-03-18 Option Award | 2020-03-20 6:07 pm | N/A 2030-03-17 | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 300,000 | $0 | 425,000 (Direct) | View |
| 2019-09-16 Option Award | 2019-09-17 7:00 pm | N/A 2029-09-15 | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 375,000 | $0 | 375,000 (Direct) | View |
Ownership | 2019-09-17 6:22 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 0 | $0 | 0 (Direct) | View |